Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A <scp>CIBMTR</scp> analysis
Narendranath Epperla, Hamza Hashmi, Kwang Woo Ahn, Mariam Allbee‐Johnson, Andy I. Chen, Baldeep Wirk, Jennifer A. Kanakry, Lazaros J. Lekakis, Mohamed A. Kharfan‐Dabaja, Michael Scordo, Peter A. Riedell, Tania Jain, Mazyar Shadman, Craig S. Sauter, Mehdi Hamadani, Alex F. Herrera, Sairah Ahmed
Abstract
Data will be available on the CIBMTR public website. Appendix S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
Chimeric antigen receptorMedicineCentral nervous systemLymphomaAntigenReceptorImmunologyOncologyImmunotherapyCancer researchInternal medicineImmune systemCAR-T cell therapy research